SHS Gesellschaft für Beteiligungsmanagement mbH
BuildingEuropean
HealthcareChampions
Are you ready to
shape the status quo
of healthcare?
We are.

Mission

With our investments, SHS Capital supports fast-growing companies in their mission to become European healthcare champions.

Located in the beautiful German university city of Tübingen, SHS Capital has been investing in innovative companies in the healthcare sector since its foundation in 1993. Today, we are the leading German healthcare dedicated private equity fund.

In addition to the capital provided, we give our partners access to our network, which has developed over more than 30 years of experience in the healthcare sector. Furthermore, we have extensive expertise in the areas of market access, reimbursement, marketing/sales, M&A and exit.

At a
Glance

Welcome to SHS Capital.

YEARS OF HISTORY 30
FUND GENERATIONS 6
INVESTMENTS
since founding (>)
70
EXITS
since founding (>)
45
SHS VI FUND VOLUME
in mEUR (ca.)
270
DEALFLOW
cases per year (>)
1.000

FAQ's

These are the most asked questions.

What is the average investment ticket size of SHS?

Transactions with enterprise values (EV) of up to 150m EUR are relevant for us. Our equity tickets are typically in the 10-50m EUR range.

Which regions are relevant for investments?

SHS is able to invest in all European countries.

In which company phases do you invest?

We are specialized in healthcare companies in growth situations, which can be SMEs as well as scale-up companies. For scale-up companies, revenues with seven-digit figures as well as double-digit growth rates need to be given to be relevant for SHS.

Are you also doing minorities?

Yes, SHS is flexible in its mandate, which means we are able to invest in both, majority as well as minority situations.

How can I invest in SHS funds?

Reach out to us to explore ways of a potential partnership - for example via the contact form on our investor site.

Reach out to us to join SHS’ unique healthcare network of the leading European scientists, entrepreneurs and investors.
Talk to us